en · de · es · fr · pt
aod-9604-notes.peptides6155.com › Faq › Mechanism And Regulatory Status — Hands-On Walkthrough

Mechanism And Regulatory Status — Hands-On Walkthrough

By Editorial Desk · published 2025-07-25 · last reviewed 2025-09-09 · Faq

hGH fragment raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2025-09-09. Anything still debated is marked as such rather than presented as settled.

Mechanism and Regulatory Status

Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.

Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.

Regulatory and Analytical Context

In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.

Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.

Aod-9604 at a glance

PropertyValueNotes
Typical storage temperature-20 °CLyophilized peptide; protect from moisture and light.
Typical analytical methodHPLC and mass spectrometryUsed to confirm identity and estimate purity.
Common synonymsAOD9604; hGH 176-191Naming varies by supplier and publication.
Disulfide bondsOneAffects folded structure and stability.
Typical research purity≥95%Value depends on supplier and analytical method.

Mechanism And Metabolic Effects

Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.

A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.

Related pages on this site

Identity And Research Background

AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.

AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.

Background and Molecular Identity

Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.

AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.

Further detail

The four substrates of this enzyme are cinnamic acid, reduced nicotinamide adenine dinucleotide phosphate (NADPH), oxygen, and a proton. Its products are p-coumaric acid, oxidised NADP+, and water. It participates in phenylalanine metabolism and phenylpropanoid biosynthesis, especially of flavonoids in plants. The enzyme is a cytochrome P450 protein containing heme. It requires a partner cytochrome P450 reductase for functional expression. This uses nicotinamide adenine dinucleotide phosphate (NADPH).

== Eighth Ministry == On 1 December 1986, following the 1986 election on 1 November, the Ministry was reconstituted by the Governor, Walter Campbell, and served until the Ahern Ministry was sworn in on 1 December 1987. Neil Turner left Parliament, and Paul Clauson was appointed to the resulting cabinet vacancy. As with the Seventh Ministry, all cabinet members were members of the National Party. On 25 November 1987, Bjelke-Petersen dismissed three ministers and appointed replacements. The following day, a meeting of 48 of the 49 National members was convened, and a spill motion was carried 39–8, after which a ballot was held for the leadership, which was won by Mike Ahern. Ahern phoned the Governor and arranged to forward a document signed by 47 members to Government House supporting his leadership. On 1 December, after significant pressure and realising his position, Bjelke-Petersen resigned, and an hour later, all ministers' commissions were terminated and a two-man Ahern Ministry was sworn in.

The shortage of manpower proved to be decisive as well. During the war, the Slovak National Council brought its demands to the young Austrian Emperor, Franz Joseph I, who seemed to take a note of it and promised support for the Slovaks against the revolutionary radical Hungarians. However the moment the revolution was over, Slovak demands were forgotten. These demands included an autonomous land within the Austrian Empire called "Slovenský kraj" which would be eventually led by a Serbian prince. This act of ignorance from the Emperor convinced the Slovak and the Czech elite who proclaimed the concept of Austroslavism as dead. Disgusted by the Emperor's policy, in 1849, Ľudovít Štúr, the person who codified the first largely used Slovak language, wrote a book he would name Slavdom and the World of the Future. This book served as a manifesto where he noted that Austroslavism was not the way to go anymore. He also wrote a sentence that often serves as a quote until this day: "Every nation has its time under God's sun, and the linden [a symbol of the Slavs] is blossoming, while the oak [a symbol of the Teutons] bloomed long ago." He expressed confidence in the Russian Empire however, as it was the only country of Slavs that was not dominated by anybody else, yet it was one of the most powerful nations in the world. He often symbolized Slavs as being a tree, with "minor" Slavic nations being branches while the trunk of the tree was Russian.

Iraqi authorities announce that the US transferred the diplomatic and logistics hub at Baghdad International Airport to Iraq prior to the withdrawal of American soldiers from the country. Chinese leader Xi Jinping meets Trump at the White House during his first visit to Washington in a decade. The two leaders discuss trade, artificial intelligence, Taiwan and international conflicts, and agree to extend the existing US–China trade truce by two months. September 25 – Cities and states across the United States, including Lexington, Nashville, New Orleans, and Portland, hold commemorations honoring former American country singer Dolly Parton including the 9 to 5 song one month after her death. California becomes the first U.S. state to designate September 25 as Dolly Parton Day. September 26 A powerful nor'easter strikes the northeast United States. A New York City Housing Authority employee is killed by a falling tree in Brooklyn. Trump rejects Iran's seven-day ceasefire proposal over nuclear concerns. The Wall Street Journal reports that he privately expects U.S. bombing to resume after the midterm elections in November, although the scale remains undecided amid dwindling munitions stockpiles. September 27 – Trump says that he still expected more talks to resume with Iran during the week. Trump claims that Iran "wanted to make a deal," but they "overplayed their hand" by offering conditions that the US "would have maybe agreed to a year ago." September 28 SpaceX's Starship achieves orbit for the first time, and deploys 26 "next generation" Starlink V3 satellites.

n RCHNHC(O)OC(O) → [N(H)CH(R)CO)]n + n CO2 Poly-L-lysine has been prepared from N-carbobenzyloxy-α-N-carboxy-L-lysine anhydride, followed by deprotection with phosphonium iodide. Peptide synthesis from NCAs does not require protection of the amino acid functional groups. N-Substituted NCAs, such as sulfenamide derivatives have also been examined. The ring-opening polymerization of NCAs is catalyzed by metal catalysts. The polymerization of NCA’s have been considered as a prebiotic route to polypeptides. NCAs can also be used to form amides and lactams by reaction of carboxylic acids and isocyanates. Dakin–West reaction Glycine N-carboxyanhydride, the parent NCA

Sources: en.wikipedia.org

Supporting material

The iodine pit, also called the iodine hole or xenon pit, is a temporary disabling of a nuclear reactor due to the buildup of short-lived neutron poisons in the reactor core. The main isotope responsible is 135Xe, mainly produced by beta decay of 135I. 135I is a weak neutron absorber, while 135Xe is the strongest known neutron absorber. When 135Xe builds up in the fuel rods of a reactor, it significantly lowers their reactivity, by absorbing a significant amount of the neutrons that provide the nuclear reaction. The presence of 135I and 135Xe in the reactor is one of the main reasons for its power fluctuations in reaction to change of control rod positions. The buildup of short-lived fission products acting as nuclear poisons is called reactor poisoning, or xenon poisoning. The buildup of stable or long-lived neutron poisons is called reactor slagging.

=== Lixisenatide in neurodegenerative diseases === Results from a research work which was done by McClean PL et al. demonstrated that the GLP-1 receptor agonists liraglutide and lixisenatide which are on the market as treatments for type 2 diabetes show promise as potential drug treatments of Alzheimer disease AD. Lixisenatide was equally effective at a lower dose compared to liraglutide in some of the measured parameters after ten weeks of daily intraperitoneal injections with liraglutide (2.5 or 25 nmol/kg) or lixisenatide (1 or 10 nmol/kg) or saline of APP/PS1 mice at an age when amyloid plaques had already formed. When analyzing synaptic plasticity in the hippocampus, LTP was strongly increased in APP/PS1 mice by either drug, with more effectiveness accomplished with lixisenatide. The reduction of synapse numbers seen in APP/PS1 mice was prevented by the two drugs. The amyloid plaque load and dense-core Congo red positive plaque load in the cortex were reduced by both drugs at all doses. The chronic inflammation response (microglial activation) was also reduced by all treatments. Cai HY et al. demonstrated in a study that lixisenatide could reduce amyloid plaques, neurofibrillary tangles and neuroinflammation in the hippocampi of 12-month-old APP/PS1/tau female mice; activation of PKA-CREB signaling pathway and inhibition of p38-MAPK might be the important mechanisms in the neuroprotective function of lixisenatide. So, lixisenatide might have the potential to be developed as a novel therapy for AD.

=== August 2008 === On 8 August 2008, Vladimir Socor, the political analyst of Jamestown Foundation, wrote that the Ossetian attacks forced the Georgian Government to respond since sticking to no-response policy "would have resulted in irreparable human, territorial, and political losses" for Georgia and Georgian response was "legally within the country's rights under international law and militarily commensurate with the attacks." Socor also criticized NATO for not giving MAP to Georgia since it provoked Russia to become aggressive towards Georgia. Robert Parsons wrote: "One fact is clear: the Kremlin's troops would not be in South Ossetia today if Georgia were a loyal ally." He argued that Russia was provoked by Kosovo's declaration of independence and Georgia's desire to become a NATO member. On 9 August 2008, Ralph Peters suggested that Russia counted that the world would be distracted by 2008 Summer Olympics and encouraged the Ossetian provocation. Peters wrote on 12 August that he was "seeing the emergence of a rogue military power with a nuclear arsenal" and Russia made it clear that it would not approve of freedom and self-rule in its neighbours. Peters noted that anyone "above the grade of private" knew that such a large-scale Russian "response" was not spontaneous since it was impossible "even to get one armored brigade over the Caucasus Mountains" without lengthy planning." Peters compared the Russian attack on Georgia to German invasion of Czechoslovakia.

=== Endothelial colony forming cell === Endothelial colony forming cells are a late outgrowth cell type; that is, they are only isolated after significantly longer culture than CFU-Hill cells. ECFCs are isolated by plating peripheral blood mononuclear fraction on collagen-coated plates, removing non-adherent cells, and culturing for weeks until the emergence of colonies with a distinctive cobblestone morphology. These cells are phenotypically similar to endothelial cells and have been shown to create vessel-like structures in vitro and in vivo. In 2019, David Smadja described a standardized protocol for the isolation and culture of endothelial colony-forming cells (ECFCs) in humans. This was followed in 2023 by a publication surveying laboratory practices among teams working with these cells, conducted under the auspices of the International Society on Thrombosis and Haemostasis Vascular Biology Scientific Subcommittee. In 2025, a review emphasized the unique vasculogenic and immunomodulatory properties of cord blood-derived ECFCs (CB-ECFCs), highlighting their high proliferative capacity, immune-privileged status, and therapeutic potential in vascular regeneration and tissue engineering.

Sources: en.wikipedia.org

Supporting material

=== Salt of hartshorn === Compositions containing ammonium carbonate have long been known. They were once produced commercially, formerly known as sal volatile or salt of hartshorn. It was obtained by the dry distillation of nitrogenous organic matter such as hair, horn, leather. In addition to ammonium bicarbonate, this material contains ammonium carbamate (NH4CO2NH2), and ammonium carbonate ((NH4)2CO3). It is sometimes called ammonium sesquicarbonate. It possesses a strong ammoniacal smell, and on digestion with alcohol, the carbamate is dissolved leaving a residue of ammonium bicarbonate. A similar decomposition takes place when the sesquicarbonate is exposed to air.

Related peer-reviewed clinical research documented the successful short-term implantation of a remotely programmable insulin delivery system in humans, reflecting the collaboration between Sandia engineers and University of New Mexico clinicians. These efforts represent an important component of the early development of implantable insulin delivery systems, highlighting the role of U.S. national laboratories in advancing biomedical device technology alongside academic and commercial research.

== History == The first IUD was developed in 1909 by the German physician Richard Richter of Waldenburg. Unlike modern intrauterine devices, early interuterine (from Latin inter-, meaning "between", as opposed to intra-) devices crossed both the vagina and the uterus, causing a high rate of pelvic inflammatory disease. Ernst Gräfenberg, another German physician (after whom the G-spot is named), created the first Ring IUD, Gräfenberg's ring, made of silver filaments. His work was suppressed during the Nazi regime, when contraception was considered a threat to Aryan women. In 1935, Gräfenberg, who was Jewish, was in jail in Berlin and Margaret Sanger paid a ransom to have him released. He moved to the United States and opened a private practice in New York, New York. His colleagues H. Hall and M. Stone took up his work after his death and created the stainless steel Hall-Stone Ring. Dr. Jack Lippes helped begin the increase of IUD use in the United States in the late 1950s. In this time, thermoplastics, which can bend for insertion and retain their original shape, became the material used for first-generation IUDs. Lippes also devised the addition of the nylon string to facilitate IUD removal. Lippes and his friend Paul Bronnenkant, a plastics developer, crafted the first Lippes Loop in Bronnenkant's kitchen, heating and molding the plastic on cookie sheets in the oven. His trapezoid-shaped Lippes Loop IUD became one of the most popular first-generation IUDs. In the following years, many different-shaped plastic IUDs were invented and marketed.

This abuse of power by local leaders exacerbated the violent purges and terror campaigns carried out by Stalin against members of the party deemed to be traitors. With the Great Purge (1936–1938), Stalin rid himself of internal enemies in the party and rid the Soviet Union of any alleged socially dangerous and counterrevolutionary person who might have offered legitimate political opposition to Marxism–Leninism. Stalin allowed the secret police NKVD (People's Commissariat for Internal Affairs) to rise above the law and the GPU (State Political Directorate) to use political violence to eliminate any person who might be a threat, whether real, potential, or imagined. As an administrator, Stalin governed the Soviet Union by controlling the formulation of national policy, but he delegated implementation to subordinate functionaries. Such freedom of action allowed local communist functionaries much discretion to interpret the intent of orders from Moscow, but this allowed their corruption. To Stalin, the correction of such abuses of authority and economic corruption were responsibility of the NKVD. In the 1937–1938 period, the NKVD arrested 1.5 million people, purged from every stratum of Soviet society and every rank and file of the party, of which 681,692 people were killed as enemies of the state.

== Names == The adjective Müllerian is written either Müllerian or müllerian, depending on the governing style guide; the derived term with the prefix anti- is then anti-Müllerian, anti-müllerian, or antimüllerian. The Müllerian ducts are named after Johannes Peter Müller. A list of the names that have been used for the antimüllerian hormone is as follows. For the sake of simplicity, this list ignores some orthographic variations; for example, it gives only one row for "Müllerian-inhibiting hormone", although there are four acceptable stylings thereof (capital M or lowercase m, hyphen or space).

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 approved for weight loss?

No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.

Why is AOD-9604 banned in sports?

The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.

Does AOD-9604 raise growth hormone levels?

It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.

Is AOD-9604 approved for medical use?

No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.

Network